<unk>  is a normochromic, normocytic<unk>  commonly seen in premature infants cared for in the neonatal intensive care unit. Normally, all the newborns develop<unk>  during the first few weeks of their life after birth. Decreased erythropoietin production, increased erythropoietin metabolism, and shortened RBC lifespan leads to<unk>  in newborns. Term infants tolerate it well and do not require any treatment. This physiological<unk>  in newborns resolves with increasing age. Whereas, premature infants develop<unk>  rapidly and more profoundly. Blood loss during phlebotomy and other illness related to<unk>  contribute to the development of<unk> . Severity of symptoms varies with the blood hemoglobin levels. Treatment involves blood transfusion and recombinant human erythropoietin therapy.
Anemia of prematurity
Neonatal polycythemia
Haemorrhagic disease of the newborn
Hemolytic disease of the newborn 
Hemolytic disease of the newborn
Neonatal sepsis
Neonatal malaria
Shaken baby syndrome